These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 30188001)
1. Epithelial down-regulation of the miR-200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition. Mehta SJ; Lewis A; Nijhuis A; Jeffery R; Biancheri P; Di Sabatino A; Feakins R; Silver A; Lindsay JO J Cell Mol Med; 2018 Nov; 22(11):5617-5628. PubMed ID: 30188001 [TBL] [Abstract][Full Text] [Related]
2. miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Chen Y; Xiao Y; Ge W; Zhou K; Wen J; Yan W; Wang Y; Wang B; Qu C; Wu J; Xu L; Cai W Cell Death Dis; 2013 Mar; 4(3):e541. PubMed ID: 23492772 [TBL] [Abstract][Full Text] [Related]
3. Cadmium exposure upregulates SNAIL through miR-30 repression in human lung epithelial cells. Tanwar VS; Zhang X; Jagannathan L; Jose CC; Cuddapah S Toxicol Appl Pharmacol; 2019 Jun; 373():1-9. PubMed ID: 30998937 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1. Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477 [TBL] [Abstract][Full Text] [Related]
6. MiR-200a negatively regulates TGF-β Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases - hallmark of epithelial-mesenchymal transition. Zidar N; Boštjančič E; Jerala M; Kojc N; Drobne D; Štabuc B; Glavač D J Cell Mol Med; 2016 Oct; 20(10):1813-20. PubMed ID: 27113480 [TBL] [Abstract][Full Text] [Related]
8. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542 [TBL] [Abstract][Full Text] [Related]
9. In Crohn's disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts. Nijhuis A; Biancheri P; Lewis A; Bishop CL; Giuffrida P; Chan C; Feakins R; Poulsom R; Di Sabatino A; Corazza GR; MacDonald TT; Lindsay JO; Silver AR Clin Sci (Lond); 2014 Sep; 127(5):341-50. PubMed ID: 24641356 [TBL] [Abstract][Full Text] [Related]
10. MiR-21 regulates epithelial-mesenchymal transition in intestinal fibrosis of Crohn's disease by targeting PTEN/mTOR. Wang Z; Zhou H; Cheng F; Zhang Z; Long S Dig Liver Dis; 2022 Oct; 54(10):1358-1366. PubMed ID: 35504804 [TBL] [Abstract][Full Text] [Related]
11. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer. Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806 [TBL] [Abstract][Full Text] [Related]
12. miRNA and mRNA expression profiling identifies members of the miR-200 family as potential regulators of epithelial-mesenchymal transition in pterygium. Engelsvold DH; Utheim TP; Olstad OK; Gonzalez P; Eidet JR; Lyberg T; Trøseid AM; Dartt DA; Raeder S Exp Eye Res; 2013 Oct; 115():189-98. PubMed ID: 23872359 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer. Basu S; Chaudhary A; Chowdhury P; Karmakar D; Basu K; Karmakar D; Chatterjee J; Sengupta S Gene; 2020 Mar; 730():144264. PubMed ID: 31759982 [TBL] [Abstract][Full Text] [Related]
14. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
15. Mechanisms of LPS-induced epithelial mesenchymal transition in bEECs. Sun M; Song P; Zhao Y; Li B; Wang P; Cong Z; Hua S Theriogenology; 2024 Mar; 216():30-41. PubMed ID: 38154204 [TBL] [Abstract][Full Text] [Related]
16. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance. Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812 [TBL] [Abstract][Full Text] [Related]
17. Antcin-A Modulates Epithelial-to-Mesenchymal Transition and Inhibits Migratory and Invasive Potentials of Human Breast Cancer Cells via p53-Mediated miR-200c Activation. Kumar KJS; Vani MG; Hsieh HW; Lin CC; Wang SY Planta Med; 2019 Jul; 85(9-10):755-765. PubMed ID: 31185503 [TBL] [Abstract][Full Text] [Related]
18. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1. Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L Nephron; 2018; 138(3):231-242. PubMed ID: 29227974 [TBL] [Abstract][Full Text] [Related]
19. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
20. The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression. Gulei D; Magdo L; Jurj A; Raduly L; Cojocneanu-Petric R; Moldovan A; Moldovan C; Florea A; Pasca S; Pop LA; Moisoiu V; Budisan L; Pop-Bica C; Ciocan C; Buiga R; Muresan MS; Stiufiuc R; Ionescu C; Berindan-Neagoe I Cell Death Dis; 2018 Jan; 9(2):66. PubMed ID: 29352232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]